Described herein are pharmaceutical packaging systems which protect against oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate prescription drugs, this kind of methods which include a syringe with the oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with quite lower permea